NanoViricides Recent Press Releases
Imagine coursing through the blood stream, chasing through the body, grabbing and destroying the offending virus particles. NanoViricides, Inc. is striving to bring this imagination to fruition. A nanoviricide®, as defined by the Company, is a nanomachine that is armed to destroy a particular kind of virus. Which virus? That information is programmed into the nanoviricide, akin to the postal address on an envelope.
A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune system assistance. This is the putative or designed mechanism of action of a nanoviricide. Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines), which are currently well established antiviral strategies.
Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies
Anil R. DiwanExecutive Chairman, President
Ms. Vyas was First Indian woman to be named CEO of a publicly listed US corporation
Meeta VyasChief Financial Officer
Dr. Barton has over 25 years experience in drug discovery and development
Randall BartonChief Scientific Officer
1 Controls Drive,
Shelton, CT 06484